vivo-bio-tech-ltd
Vivo Bio Tech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 16.67 | 10.15 | 11.56 |
| Operating Expense | 6.36 | 5.76 | 6.22 |
| Net Profit | 5.31 | 0.18 | 0.70 |
| Net Profit Margin | 31.85 | 1.77 | 6.06 |
| Earning Per Share | 3.56 | 0.12 | 0.47 |
| EBIDTA | 10.44 | 4.53 | 5.38 |
| Effective Tax Rate | 7.57 | 4.56 | 13.67 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 16.67 |
| Operating Expense | 6.36 |
| Net Profit | 5.31 |
| Net Profit Margin | 31.85 |
| Earning Per Share | 3.56 |
| EBIDTA | 10.44 |
| Effective Tax Rate | 7.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 44.88 | 51.62 | 51.39 |
| Operating Expenses Annual | 23.80 | 30.14 | 35.58 |
| Operating Profit Annual | 21.12 | 21.52 | 15.91 |
| Interest Annual | 7.78 | 7.65 | 3.99 |
| Depreciation | 9.29 | 9.27 | 7.44 |
| Net Profit Annual | 2.52 | 2.63 | 2.20 |
| Tax Annual | 1.53 | 1.97 | 2.27 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 44.88 |
| Operating Expenses Annual | 23.80 |
| Operating Profit Annual | 21.12 |
| Interest Annual | 7.78 |
| Depreciation | 9.29 |
| Net Profit Annual | 2.52 |
| Tax Annual | 1.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.99 | 1.47 | 1.10 |
| Cash Flow from Operations | 15.83 | 14.73 | 16.43 |
| Cash Flow from Investing | -7.95 | -4 | -51.11 |
| Cash Flow from Financing | -7.56 | -11.20 | 35.04 |
| Cash Flow at the End | 1.32 | 0.99 | 1.47 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.99 |
| Cash Flow from Operations | 15.83 |
| Cash Flow from Investing | -7.95 |
| Cash Flow from Financing | -7.56 |
| Cash Flow at the End | 1.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 47.46 | 42.35 | 31.48 |
| PBIT Margin (%) | 26.76 | 24.39 | 17.01 |
| PBT Margin (%) | 23.40 | 21.33 | 13.02 |
| Net PROFIT Margin (%) | 5.61 | 5.09 | 4.28 |
| Return On Networth / Equity (%) | 4.74 | 5.31 | 4.91 |
| Return On Networth /Employed (%) | 10.06 | 11.16 | 9.47 |
| Return On Assets (%) | 2.13 | 2.34 | 2.40 |
| Total Debt / Equity (X) | 1.23 | 1.27 | 1.05 |
| Asset Turnover Ratio (%) | 0.38 | 0.46 | 0.56 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 47.46 |
| PBIT Margin (%) | 26.76 |
| PBT Margin (%) | 23.40 |
| Net PROFIT Margin (%) | 5.61 |
| Return On Networth / Equity (%) | 4.74 |
| Return On Networth /Employed (%) | 10.06 |
| Return On Assets (%) | 2.13 |
| Total Debt / Equity (X) | 1.23 |
| Asset Turnover Ratio (%) | 0.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 77.01 | 85.51 | 91.81 |
| Total Current Assets Annual | 48.22 | 32.88 | 27.18 |
| Non Current Assets Annual | 86.58 | 87.92 | 93.12 |
| Total Shareholders Funds Annual | 54.40 | 51.87 | 47.14 |
| Total Assets Annual | 134.80 | 120.81 | 120.30 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 77.01 |
| Total Current Assets Annual | 48.22 |
| Non Current Assets Annual | 86.58 |
| Total Shareholders Funds Annual | 54.40 |
| Total Assets Annual | 134.80 |
EPS (INR)
Expected
3.51
Reported
3.51
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
